Autonomic dysfunction and arterial hypertension: together or instead?
- 00:05:44
Hypersympathicotonia: 4 mechanisms of damage to the heart and blood vessels
- 00:09:55
Heart rate: +10 bpm → +27% mortality
- 00:13:51
BP >130/80 → +34% risk of cognitive impairment
- 00:17:23
The Kerdo Index and the Wein Scale are simple tests of the autonomic nervous system.
- 00:22:21
MEMO study: the effectiveness of Mexidol in hypertension and cognitive impairment
Ebzeeva Elizaveta Yuryevna - PhD, therapist, psychotherapist, associate professor of the Department of Therapy and Polymorbid Pathology named after Academician M.S. Vovsi, Federal State Budgetary Educational Institution of Higher Professional Education, Russian Medical Academy of Postgraduate Education, Ministry of Health of the Russian Federation
Announcement:
We invite you to a presentation by Associate Professor, General Practitioner, and Psychotherapist Elizaveta Yuryevna Ebzeeva on the relationship between autonomic dysfunction and arterial hypertension. This presentation examines the pathogenic mechanisms and modern approaches to therapy.
- Why is hypersympathicotonia not just tachycardia, but a key driver of the cardiovascular continuum?
- How does autonomic nervous system dysfunction trigger oxidative stress, systemic inflammation, and endothelial dysfunction?
- Why does a 10 bpm increase in heart rate increase mortality by 27%?
The video material examines in detail the “vicious circle” of mutual aggravation of hypertension and autonomic dysfunction:
- Hemodynamic effects: vasospasm, increased blood pressure, tachycardia;
- Metabolic disorders: insulin resistance, dyslipidemia;
- Systemic inflammation: increase in IL-6, CRP, activation of the immune system;
- CNS damage: cognitive impairment, anxiety-depressive disorders.
Cognitive impairment is not a late complication, but an early sign of brain damage:
- They are detected in 73% of patients with hypertension lasting >5 years;
- The risk of dementia increases already at blood pressure >130/80 mmHg.
Watch the report to:
- To understand how autonomic dysfunction worsens the prognosis in hypertension;
- Learn to assess the state of the autonomic nervous system and cognitive functions;
- Find out why Mexidol is an evidence-based choice.
This video is a must-see for therapists, cardiologists, neurologists, and general practitioners.
- 00:05:44
Hypersympathicotonia: 4 mechanisms of damage to the heart and blood vessels
- 00:09:55
Heart rate: +10 bpm → +27% mortality
- 00:13:51
BP >130/80 → +34% risk of cognitive impairment
- 00:17:23
The Kerdo Index and the Wein Scale are simple tests of the autonomic nervous system.
- 00:22:21
MEMO study: the effectiveness of Mexidol in hypertension and cognitive impairment